Fuad El-Hibri

2013

In 2013, Fuad El-Hibri earned a total compensation of $1.3M as Executive Chairman of the Board of Directors at Emergent BioSolutions, a 8% decrease compared to previous year.

Compensation breakdown

Option Awards$258,639
Salary$726,297
Stock Awards$306,632
Other$3,904
Total$1,295,471

El-Hibri received $726.3K in salary, accounting for 56% of the total pay in 2013.

El-Hibri also received $258.6K in option awards, $306.6K in stock awards and $3.9K in other compensation.

Rankings

In 2013, Fuad El-Hibri's compensation ranked 5,519th out of 12,286 executives tracked by ExecPay. In other words, El-Hibri earned more than 55.1% of executives.

ClassificationRankingPercentile
All
5,519
out of 12,286
55th
Division
Manufacturing
1,923
out of 4,612
58th
Major group
Chemicals And Allied Products
557
out of 1,466
62nd
Industry group
Drugs
398
out of 1,160
66th
Industry
Pharmaceutical Preparations
317
out of 890
64th
Source: SEC filing on April 8, 2016.

El-Hibri's colleagues

We found five more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2013.

2013

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

2013

Steven Chatfield

Emergent BioSolutions

Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division

2013

Barry Labinger

Emergent BioSolutions

Executive Vice President, Biosciences Division

2013

Adam Havey

Emergent BioSolutions

Executive Vice President, Biodefense Division

2013

Robert Kramer

Emergent BioSolutions

Chief Financial Officer

News

You may also like